IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas
Public ClinicalTrials.gov record NCT06451341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas: Addressing Adherence Barriers Through Learning and Evidence-Informed Strategies (IM-CAPABLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this implementation science study is to learn about the experience of receiving and providing cabotegravir + rilpivirine long-acting (CAB+RPV LA) injections as treatment for human immunodeficiency virus (HIV) for people who live a significant distance from an HIV provider. The main questions it aims to answer are: * Is CAB+RPV LA feasible and acceptable to patients and staff? * What barriers and supports exist and have the most impact on receiving and providing CAB+RPV LA? * How does CAB+RPV LA affect HIV stigma, treatment satisfaction, medication adherence and viral suppression? People living with HIV who reside outside of the Omaha, Nebraska metro area and are starting CAB+RPV LA as part of regular medical care for HIV will be invited to participate in this study which involves completing questionnaires and an interview over 15 months. Clinic staff who are involved in providing HIV care and CAB+RPV LA will also provide input through questionnaires and interviews.
Study identification
- NCT ID
- NCT06451341
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- Acceptability of Intervention Measure (AIM) Behavioral
- Intervention Appropriateness Measure (IAM) Behavioral
- Feasibility of Intervention Measure (FIM) Behavioral
- HIV Stigma Scale Questionnaire Behavioral
- HIV Treatment Satisfaction Questionnaire status version (HIVTSQs12) Behavioral
- HIV Treatment Satisfaction Questionnaire change version (HIVTSQc12) Behavioral
- Needs and Barriers Assessment Behavioral
- Pre-visit Outreach Behavioral
- Qualitative interview - patient participants Behavioral
- Staff education Behavioral
- Staff Month 7 and 15 Survey - Staff Burden and Engagement Behavioral
- Qualitative interview - staff Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2024
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
- Last update posted
- Jul 23, 2026
2024 – 2028
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Myrtue Medical Center | Harlan | Iowa | 51537 | — |
| Shenandoah Medical Center | Shenandoah | Iowa | 51601 | — |
| Nebraska Medicine Grand Island Clinic | Grand Island | Nebraska | 68803 | — |
| University of Nebraska Specialty Care Center | Omaha | Nebraska | 68106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06451341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06451341 live on ClinicalTrials.gov.